Open Label Comparative Trial of Dinoprostone Plus or Minus Oxytocin Versus Oxytocin Alone in Cervical Ripening for Labor Induction
Phase 4
Terminated
- Conditions
- Vaginal DeliveryCesarean Section
- Interventions
- Registration Number
- NCT01190163
- Lead Sponsor
- Ferring Pharmaceuticals
- Brief Summary
This is a comparative trial between oxytocin alone and dinoprostone for cervical ripening in unfavorable cervix pregnant women with 38 or more weeks of gestational age.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 170
Inclusion Criteria
- Singleton pregnancy
- Gestational age ≥ 38 weeks
- Fetal cephalic presentation
- Bishop score < 6
Exclusion Criteria
- No uterine scar (no previous delivery by caesarean section)
- No more than 3 previous vaginal births
- No condition that disallows use of prostaglandins for induction of labor
- Premature rupture of the membranes
- Oligohydramnios
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description A Dinoprostone - B Oxytocin -
- Primary Outcome Measures
Name Time Method Vaginal birth delivery within 24 hours and C-section rate 24 hours
- Secondary Outcome Measures
Name Time Method Treatment failure rate 24 hours Uterine hyperstimulation and/or fetal distress 24 hours Use of additional oxytocin 24 hours
Trial Locations
- Locations (4)
Hospital Maternidade Leonor Mendes de Barros
🇧🇷São Paulo, Brazil
Hospital M Boi Mirim
🇧🇷São Paulo, Brazil
Hospital Municipal Universitário - Faculdade de Medicina do ABC
🇧🇷São Bernardo, São Paulo, Brazil
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
🇧🇷Ribeirão Preto, São Paulo, Brazil